Defense Secretary Pete Hegseth posted a video to X on Tuesday announcing that every active-duty service member aged 30 and older will now receive an annual testosterone deficiency screening as part of their routine periodic health assessment. Troops under 30 can volunteer. The caption on the post read, "The High-T Department of War."
Within hours, two Democratic lawmakers called it dangerous. One of them called it gender-affirming care.
The new Pentagon policy folds a simple blood panel into the military's existing annual checkup cycle. If a screening flags low testosterone, the service member gets the option — not the order — to pursue testosterone replacement therapy, or TRT. Hegseth framed the move as a readiness issue, not a culture-war stunt. "We owe our warriors the absolute best medical care in the world, and this program delivers on that obligation," he said in the announcement.
The rationale isn't exotic. Testosterone levels naturally decline with age, and the military's operating environment accelerates the drop. High stress, extreme physical demands, caloric deficits, and disrupted sleep — the daily reality of special operations and combat deployments — are all documented contributors to hormonal decline. The American Urological Association estimates roughly 2% of men have clinically low testosterone, but studies in military populations suggest the rate runs higher.
Hegseth was specific about what the program isn't. "This initiative — it's not about artificial enhancement; it's about restoring and optimizing your natural capabilities, protecting your longevity, and ensuring you have the biological foundation required to sustain the fight," he said. The FDA's current labeling restricts testosterone medications to men diagnosed with hypogonadism — a clinical condition, not a lifestyle choice. The screening program identifies who actually has the condition. That's it.
So naturally, the opposition treated it like a scandal.
Sen. Tammy Duckworth said the announcement sounded "like gender-affirming care." She then pivoted to calling for hormone screenings to be extended to all service members, saying, "Let's extend hormone screenings for all of our brave servicemembers to help us identify fertility issues early." Which is an interesting move — condemn the policy, then demand it be expanded. Rep. Chrissy Houlahan went a different direction, claiming the "announcement proves that Secretary Hegseth takes direction from the far corners of the manosphere."
The manosphere. That's the rebuttal to checking whether the people we send into combat have healthy hormone levels. Not a medical argument. Not a cost analysis. Not a readiness concern. The manosphere.
Meanwhile, the Pentagon didn't invent the idea that testosterone matters for physical performance. Every branch of the military already screens for dozens of health markers annually — blood pressure, cholesterol, vision, hearing, mental health. Adding a hormone panel to a blood draw that's already happening isn't a radical expansion of government medicine. It's a line item on a lab order. The broader context here is a Trump administration push to expand access to TRT and hormone optimization, part of the "Make America Healthy Again" initiative that has driven Democrats into the unusual position of arguing against preventive healthcare.
Duckworth's framing is the one worth sitting with. She called screening troops for a documented medical condition "gender-affirming care" — a term her party spent years insisting describes essential, life-saving treatment. If checking testosterone is gender-affirming care, and gender-affirming care is healthcare, then by her own logic she just endorsed the program.
That's the problem with borrowing your opponent's language as a weapon. Sometimes it fires backward.